These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7153371)

  • 1. The effect of stimulant medication in childhood-onset pervasive developmental disorder--a case report.
    Schmidt K
    J Dev Behav Pediatr; 1982 Dec; 3(4):244-6. PubMed ID: 7153371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate an effective treatment for ADHD?
    McDougle CJ
    J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
    [No Abstract]   [Full Text] [Related]  

  • 4. [Response With Methylphenidate to ADHD-Like Symptoms in Pervasive Developmental Disorder: Does CES-1 Enzyme Gene Polymorphism Have a Role?].
    Akyol Ardıç Ü; Ercan ES; Aygüneş D; Yüce D; Durak S; Kosova B
    Turk Psikiyatri Derg; 2017; 28(2):89-94. PubMed ID: 29192941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.
    Di Martino A; Melis G; Cianchetti C; Zuddas A
    J Child Adolesc Psychopharmacol; 2004; 14(2):207-18. PubMed ID: 15319018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of stimulant medication in treating pervasive developmental disorder.
    Sporn A; Pinsker H
    Am J Psychiatry; 1981 Jul; 138(7):997. PubMed ID: 7258372
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.
    Pelham WE; Gnagy EM; Burrows-Maclean L; Williams A; Fabiano GA; Morrisey SM; Chronis AM; Forehand GL; Nguyen CA; Hoffman MT; Lock TM; Fielbelkorn K; Coles EK; Panahon CJ; Steiner RL; Meichenbaum DL; Onyango AN; Morse GD
    Pediatrics; 2001 Jun; 107(6):E105. PubMed ID: 11389303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical assessment of the effect of switch from immediate-release to extended-release methylphenidate in 181 patients with isolated attention deficit/hyperactivity disorder (AD/HD) or AD/HD associated with pervasive developmental disorder].
    Sugama M; Ishizaki A
    No To Hattatsu; 2009 Nov; 41(6):436-41. PubMed ID: 19928542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant medication and attention deficit-hyperactivity disorder. The child's perspective.
    Bowen J; Fenton T; Rappaport L
    Am J Dis Child; 1991 Mar; 145(3):291-5. PubMed ID: 2003477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective open trial of guanfacine in children with pervasive developmental disorders.
    Scahill L; Aman MG; McDougle CJ; McCracken JT; Tierney E; Dziura J; Arnold LE; Posey D; Young C; Shah B; Ghuman J; Ritz L; Vitiello B
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):589-98. PubMed ID: 17069547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrospective analysis of pervasive developmental disorder patients initially diagnosed with attention deficit/hyperactivity disorder].
    Kawatani M; Nakai A; Mayumi M; Hiratani M
    No To Hattatsu; 2009 Jan; 41(1):11-6. PubMed ID: 19172810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of medication in pervasive developmental disorders.
    Sloman L
    Psychiatr Clin North Am; 1991 Mar; 14(1):165-82. PubMed ID: 1675463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of stimulant medication on academic performance, in the context of multimodal treatment, in attention deficit disorders with hyperactivity: two case reports.
    Schmidt K; Solanto MV; Sanchez-Kappraff M; Vargas P; Wein S
    J Clin Psychopharmacol; 1984 Apr; 4(2):100-3. PubMed ID: 6707235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE; Gadow KD; Sprafkin J
    Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autism and attention deficit hyperactivity disorder: pharmacological intervention].
    Fernández-Jaén A; Martín Fernández-Mayoralas D; Fernández-Perrone AL; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
    Rev Neurol; 2013 Sep; 57 Suppl 1():S205-10. PubMed ID: 23897149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.